New products and vaccines a shot in the arm for GSK By: CNBC.com News April 27, 2016 at 07:23 AM EDT Increasing sales of new products and growing demand for vaccines and consumer healthcare goods helped lift GlaxoSmithKline's sales figures 8 percent. Read More >> Related Stocks: Gsk Plc ADR